These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 2783381)

  • 1. Effects of cadmium on estrogen receptor mediated signaling and estrogen induced DNA synthesis in T47D human breast cancer cells.
    Zang Y; Odwin-Dacosta S; Yager JD
    Toxicol Lett; 2009 Jan; 184(2):134-8. PubMed ID: 19041697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Expression Rates in Invasive Breast Carcinoma: A Study of 21 Institutions.
    Mais DD; Nazarullah AN; Guidi AJ; Dintzis S; Blond BJ; Long TA; Coulter SN; Brown RW
    Arch Pathol Lab Med; 2024 Apr; ():. PubMed ID: 38631690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team.
    Jordan VC
    Breast Cancer Res Treat; 2021 Nov; 190(1):19-38. PubMed ID: 34398352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SERM Saga, Something from Nothing: American Cancer Society/SSO Basic Science Lecture.
    Jordan VC
    Ann Surg Oncol; 2019 Jul; 26(7):1981-1990. PubMed ID: 30911948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations.
    Sweeney EE; McDaniel RE; Maximov PY; Fan P; Jordan VC
    Horm Mol Biol Clin Investig; 2012 Feb; 9(2):143-163. PubMed ID: 23308083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptors.
    Yusuf R; Frenkel K
    Cancer Cell Int; 2010 Sep; 10():30. PubMed ID: 20809984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Paradox of Oestradiol-Induced Breast Cancer Cell Growth and Apoptosis.
    Maximov PY; Lewis-Wambi JS; Jordan VC
    Curr Signal Transduct Ther; 2009 May; 4(2):88-102. PubMed ID: 19809537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of HER-2 over-expression with clinico-pathological parameters in Tunisian breast carcinoma.
    Ayadi L; Khabir A; Amouri H; Karray S; Dammak A; Guermazi M; Boudawara T
    World J Surg Oncol; 2008 Oct; 6():112. PubMed ID: 18945339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.
    Craig Jordan V; Lewis-Wambi J; Kim H; Cunliffe H; Ariazi E; Sharma CG; Shupp HA; Swaby R
    Breast; 2007 Dec; 16 Suppl 2(Suppl 2):S105-13. PubMed ID: 17719781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular determinants of estrogen receptor alpha expression.
    Pinzone JJ; Stevenson H; Strobl JS; Berg PE
    Mol Cell Biol; 2004 Jun; 24(11):4605-12. PubMed ID: 15143157
    [No Abstract]   [Full Text] [Related]  

  • 11. The clonogenic growth of advanced breast tumour lesions adds no value to that of established clinical prognosticators for survival.
    Hug V; Polyzos A; Tucker S; Thames H
    Br J Cancer; 1993 Feb; 67(2):222-5. PubMed ID: 8431355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autocrine growth factors and solid tumor malignancy.
    Walsh JH; Karnes WE; Cuttitta F; Walker A
    West J Med; 1991 Aug; 155(2):152-63. PubMed ID: 1926844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-stimulation of gastrointestinal tumour cell growth by gastrin, transforming growth factor alpha and insulin like growth factor-I.
    Durrant LG; Watson SA; Hall A; Morris DL
    Br J Cancer; 1991 Jan; 63(1):67-70. PubMed ID: 1846553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in estradiol-stimulated progesterone receptor production in MCF-7 cells by epidermal growth factor and possible clinical implication for paracrine-regulated breast cancer growth.
    Cormier EM; Wolf MF; Jordan VC
    Cancer Res; 1989 Feb; 49(3):576-80. PubMed ID: 2783381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
    Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
    Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
    Koga M; Musgrove EA; Sutherland RL
    Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression.
    Dotzlaw H; Miller T; Karvelas J; Murphy LC
    Cancer Res; 1990 Jul; 50(14):4204-8. PubMed ID: 2364377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estrogen receptors (ER) and progesterone receptors (PgR) in ovarian cancer].
    Trapani A
    Minerva Ginecol; 1992 Jun; 44(6):307-12. PubMed ID: 1635652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on mechanisms of estrogen and antiestrogen action in human breast cancer.
    Horwitz KB; McGuire WL
    Recent Results Cancer Res; 1980; 71():45-58. PubMed ID: 6988916
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.